A University of Colorado Anschutz Medical Campus research team has discovered that the immunoglobulin G (IgG) antibodies in the plasma of multiple sclerosis (MS) patients are toxic to neurons, a finding the lead investigator ...
Apr 26, 2023
0
81
Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function ...
Apr 21, 2023
0
363
In a new study, researchers from The University of Texas MD Anderson Cancer Center have created the largest single-cell atlas of brain metastases from renal cell carcinoma (RCC) with matched primary and extracranial metastases, ...
Apr 18, 2023
0
1
Contrary to previous beliefs, stem cells, from which all new blood cells are formed, remain in bone marrow in the blood cancer type acute lymphocytic leukemia. This disease, however, causes a hidden defect in the stem cells ...
Apr 5, 2023
0
8
More than 10 million people are sickened by tuberculosis (TB) globally each year, resulting in 1.5 million deaths. Yet, as many as two billion people are infected with Mycobaterium tuberculosis, the bacterium that causes ...
Apr 3, 2023
0
42
In her laboratory, Cecilia Berin, Ph.D., the Bunning Professor of Food Allergy Research, studies the immune basis of allergy and tolerance to foods.
Mar 30, 2023
0
2
Memory B cells play a critical role to provide long-term immunity after a vaccination or infection. In a study published in the journal Immunity, researchers describe a distinct and novel subset of memory B cells that predict ...
Mar 22, 2023
0
63
For patients with cancer, age, cancer type, and comorbidity are associated with differential COVID-19 vaccine uptake rates, according to a study published online March 15 in Cancer.
Mar 16, 2023
0
4
A new approach that delivers a "one-two punch" to help T cells attack solid tumors is the focus of a preclinical study by researchers from the Perelman School of Medicine at the University of Pennsylvania. The findings, published ...
Mar 15, 2023
0
39
The search for new therapies to treat a rare type of non-Hodgkins lymphoma has had an unexpected success—identifying a potential molecular target to treat other related forms of lymphoma as well.
Mar 14, 2023
0
2
